Nuevocor Email Format
Biotechnology ResearchSingapore, Singapore11-50 Employees
Nuevocor, with offices in USA and Singapore, is developing genetic medicines for untreatable genetic cardiomyopathies by leveraging insights from our PrOSIA mechanobiology platform.